Roche buys diabetes application-maker mySugr in digital health push

Swiss drugmaker Roche stated on Friday it’s buying Vienna-based diabetes management platform mySugr to have an undisclosed cost because it presses into application-based digital health services for individuals struggling with the metabolic disorder.

MySugr, a independently held company that provides a logbook for cellular devices to help individuals manage their disease, had formerly got funding in the Roche Venture Fund, Roche stated inside a statement.

Roche is probably the world’s largest makers of diabetes diagnostics, including finger pricks for patients to find out bloodstream sugar levels.

(Reporting by John Miller Editing by Michael Shields)

Leave a Reply

Your email address will not be published. Required fields are marked *